Goedemiddag, hier zijn we weer van de WCRI in Hong Kong’ Ik sta hier met Tom Arrison. Hij heeft  belangrijk werk gedaan op het gebied van reproductie- en replicatieonderzoek. So please tell us about it, a bit about who you are and what you do. So, I work at the US National Academies of Sciences, Engineering, and Medicine. We’re a non-profit group that does studies of science and technology issues for federal sponsors and also with foundation funding. And I was here in Hong Kong to talk about our new report ‘Reproducibility and replicability in science’. The report came out last month and it provides an overview and detailed recommendations and findings on the importance of reproducibility and replicability and also what the many stakeholders in the scientific enterprise should be doing to facilitate reproducibility and replicability. And so, in a broad sense, what is needed to facilitate reproducibility and replicability is complete information about the study, how it was done, access to the data, access to the code, computational methods and computational environment and also the tools and infrastructure to make data and code available on a persistent basis, are also necessary, so that ought to be included. If you look at it professionally, from the viewpoint of a funding organisation, then do you see an important role for us? 
Yes, I think that the funding agencies, the key thing that they need to do is, kinda, set the guidelines with community guidance and input on what needs to be made available. And also, to support the tools and infrastructure that the research community needs to use to make reproducible research possible. Maybe as a final question, if you – we – had to choose between improving reproducibility and replicability, and actually funding replication studies, what would be the most important choice? Right, so it depends. I think, in a general sense, reproducibility and replicability are important, but they’re only part of the total picture in gaining confidence in scientific results. And there is meta-analysis, there is other confirmatory analysis that’s done in many fields. And replication studies, I think, the criteria for when you should fund those would be when the, certainly, when the results would be important for policy making decisions or public health, or other kinda important for society type of results. Also, when there are questions, whether differences or surprising, unexpected results you might want to find replication of that. Or when there are kind of obvious questions that concern methodology. All right, thank you very much and good luck with your work. - Thank you very much!